Back to Search Start Over

Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England.

Authors :
Knock ES
Whittles LK
Lees JA
Perez-Guzman PN
Verity R
FitzJohn RG
Gaythorpe KAM
Imai N
Hinsley W
Okell LC
Rosello A
Kantas N
Walters CE
Bhatia S
Watson OJ
Whittaker C
Cattarino L
Boonyasiri A
Djaafara BA
Fraser K
Fu H
Wang H
Xi X
Donnelly CA
Jauneikaite E
Laydon DJ
White PJ
Ghani AC
Ferguson NM
Cori A
Baguelin M
Source :
Science translational medicine [Sci Transl Med] 2021 Jul 14; Vol. 13 (602). Date of Electronic Publication: 2021 Jun 22.
Publication Year :
2021

Abstract

We fitted a model of SARS-CoV-2 transmission in care homes and the community to regional surveillance data for England. Compared with other approaches, our model provides a synthesis of multiple surveillance data streams into a single coherent modeling framework, allowing transmission and severity to be disentangled from features of the surveillance system. Of the control measures implemented, only national lockdown brought the reproduction number ( R <subscript>t</subscript> <superscript>eff</superscript> ) below 1 consistently; if introduced 1 week earlier, it could have reduced deaths in the first wave from an estimated 48,600 to 25,600 [95% credible interval (CrI): 15,900 to 38,400]. The infection fatality ratio decreased from 1.00% (95% CrI: 0.85 to 1.21%) to 0.79% (95% CrI: 0.63 to 0.99%), suggesting improved clinical care. The infection fatality ratio was higher in the elderly residing in care homes (23.3%, 95% CrI: 14.7 to 35.2%) than those residing in the community (7.9%, 95% CrI: 5.9 to 10.3%). On 2 December 2020, England was still far from herd immunity, with regional cumulative infection incidence between 7.6% (95% CrI: 5.4 to 10.2%) and 22.3% (95% CrI: 19.4 to 25.4%) of the population. Therefore, any vaccination campaign will need to achieve high coverage and a high degree of protection in vaccinated individuals to allow nonpharmaceutical interventions to be lifted without a resurgence of transmission.<br /> (Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).)

Details

Language :
English
ISSN :
1946-6242
Volume :
13
Issue :
602
Database :
MEDLINE
Journal :
Science translational medicine
Publication Type :
Academic Journal
Accession number :
34158411
Full Text :
https://doi.org/10.1126/scitranslmed.abg4262